share_log

T2 Biosystems | UPLOAD: Others

T2 Biosystems | UPLOAD: Others

T2 Biosystems | UPLOAD:其他
美股SEC公告 ·  2024/05/31 01:41

Moomoo AI 已提取核心訊息

T2 Biosystems, Inc., a medical device company, has filed a Registration Statement on Form S-3 with the United States Securities and Exchange Commission (SEC) on May 28, 2024. The SEC, through a letter dated May 30, 2024, addressed to John Sperzel, President, CEO, and Chairman of T2 Biosystems, has informed the company that it has not reviewed and will not review the registration statement. The SEC's letter also reminds the company and its management of their responsibility for the accuracy and adequacy of their disclosures, irrespective of the SEC's review process. The SEC has directed any further inquiries to Conlon Danberg and has cited Rules 460 and 461, which pertain to requests for acceleration of the registration process.
T2 Biosystems, Inc., a medical device company, has filed a Registration Statement on Form S-3 with the United States Securities and Exchange Commission (SEC) on May 28, 2024. The SEC, through a letter dated May 30, 2024, addressed to John Sperzel, President, CEO, and Chairman of T2 Biosystems, has informed the company that it has not reviewed and will not review the registration statement. The SEC's letter also reminds the company and its management of their responsibility for the accuracy and adequacy of their disclosures, irrespective of the SEC's review process. The SEC has directed any further inquiries to Conlon Danberg and has cited Rules 460 and 461, which pertain to requests for acceleration of the registration process.
醫療器械公司T2 Biosystems於2024年5月28日向美國證券交易所(SEC)提交了S-3表格的註冊聲明。 SEC在2024年5月30日發給T2 Biosystems總裁,CEO和董事長John Sperzel的信中通知該公司,它尚未審核並且不會審核該註冊聲明。 SEC的信還提醒公司及其管理層,他們要對其披露的準確性和充分性負責,無論SEC的審核過程如何。 SEC已將所有進一步詢問引導給Conlon Danberg,並引用了規則460和461,這些規則涉及對註冊過程加速申請的請求。
醫療器械公司T2 Biosystems於2024年5月28日向美國證券交易所(SEC)提交了S-3表格的註冊聲明。 SEC在2024年5月30日發給T2 Biosystems總裁,CEO和董事長John Sperzel的信中通知該公司,它尚未審核並且不會審核該註冊聲明。 SEC的信還提醒公司及其管理層,他們要對其披露的準確性和充分性負責,無論SEC的審核過程如何。 SEC已將所有進一步詢問引導給Conlon Danberg,並引用了規則460和461,這些規則涉及對註冊過程加速申請的請求。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息